|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C12N 15/13 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| C07K 14/71 | |||
| A61K 39/00 |
| (11) | Number of the document | 2785742 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12846470.8 |
| Date of filing the European patent application | 2012-11-01 | |
| (97) | Date of publication of the European application | 2014-10-08 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/062929 |
| Date | 2012-11-01 |
| (87) | Number | WO 2013/067098 |
| Date | 2013-05-10 |
| (30) | Number | Date | Country code |
| 201161554758 P | 2011-11-02 | US | |
| 201261609581 P | 2012-03-12 | US |
| (72) |
KE, Yaohuang, US
LEE, Sum Wai Pierre, US
ZHANG, Yongke, US
YU, Guo-Liang, US
ZHU, Weimin, US
|
| (73) |
Apexigen, Inc.,
75 Shoreway Road, Suite C, San Carlos, CA 94070,
US
|
| (54) | ANTI-KDR ANTIBODIES AND METHODS OF USE |
| ANTI-KDR ANTIBODIES AND METHODS OF USE |